ProFund Advisors »

Aeglea Biotherapeutics shares owned by ProFund Advisors

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by ProFund Advisors from 13F filings

Historical chart of ProFund Advisors investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by ProFund Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $346k 15k 23.28
2024-09-30 $414k 14k 29.41
2024-06-30 $296k 13k 23.51